Pubblicazioni IOV anno corrente 2020
TitoloAutoriRivista
A new standard of care for patients with high-risk rhabdomyosarcoma? - Authors' replyBisogno,G., Ferrari,A., Melcon,S. G., De Salvo Gian Luca, Bergeron,C., Jenney,M.Lancet Oncology
Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancerBanna,G. L., Urzia,V., Benanti,C., Pitrè,A., Lipari,H., Di Quattro,R., De Giorgi,U., Schepisi,G., Basso Umberto, Bimbatti,D., Rundo,F., Libra,M., Malatino,L.Supportive Care in Cancer
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF(V600)-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trialDummer,R., Brase,J. C., Garrett,J., Campbell,C. D., Gasal,E., Squires,M., Gusenleitner,D., Santinami,M., Atkinson,V., Mandalà ,M., Chiarion-Sileni Vanna, Flaherty,K., Larkin,J., Robert,C., Kefford,R., Kirkwood,J. M., Hauschild,A., Schadendorf,D., Long,G. V.Lancet Oncology
An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45Bjelic-Radisic,V., Cardoso,F., Cameron,D., Brain,E., Kuljanic,K., da Costa,R. A., Conroy,T., Inwald,E. C., Serpentini Samantha, Pinto,M., Weis,J., Morag,O., Lindviksmoen Astrup,G., Tomaszweksi,K. A., Pogoda,K., Sinai,P., Sprangers,M., Aaronson,N., Velikova,G., Greimel,E. (...)Annals of Oncology
Anti-PD1 antibodies in patients aged ? 75 years with metastatic melanoma: A retrospective multicentre studyRidolfi,L., De Rosa,F., Petracci,E., Tanda,E. T., Marra,E., Pigozzo Jacopo, Marconcini,R., Guida,M., Cappellini,G. C. A., Gallizzi,G., Occelli,M., Pala,L., Gambale,E., Bersanelli,M., Galdo,G., Cortellini,A., Morgese,F., Zoratto,F., Stucci,L. S., Strippoli,S. (...)Journal of Geriatric Oncology
Biomimetic cellular vectors for enhancing drug delivery to the lungsEvangelopoulos,M., Yazdi,I. K., Acciardo,S., Palomba,R., Giordano,F., Pasto' Anna, Sushnitha,M., Martinez,J. O., Basu,N., Torres,A., Hmaidan,S., Parodi,A., Tasciotti,E.Scientific Reports
Combination of Immunotherapy and Radiotherapy—The Next Magic Step in the Management of Lung Cancer?Hendriks,L. E. L., Menis Jessica, De Ruysscher,D. K. M., Reck,M.Journal of thoracic oncology
Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast CancerPantano,F., Rossi Elisabetta, Iuliani,M., Facchinetti Antonella, Simonetti,S., Ribelli,G., Zoccoli,A., Vincenzi,B., Tonini,G., Zamarchi Rita, Santini,D.Scientific Reports
E-Coaching: the DianaWeb study to prevent breast cancer recurrencesGianfredi,V., Nucci Daniele, Balzarini,M., Acito,M., Moretti,M., Villarini,A., Villarini,M.La Clinica terapeutica
Extent of primary DNA damage measured by the comet assay in health professionals exposed to antineoplastic drugs: A systematic review and meta-analysisGianfredi,V., Nucci Daniele, Fatigoni,C., Salvatori,T., Villarini,M., Moretti,M.International Journal of Environmental Research and Public Health
Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: Results from an international, multi-institutional, retrospective analysisNapolitano,A., Provenzano,S., Colombo,C., Vitellaro,M., Brunello Antonella, Badalamenti,G., Nannini,M., Ibrahim,T., Hohenberger,P., Gasperoni,S., Gennatas,S., Jones,R. L., Hindi,N., Martin-Broto,J., Spalato Ceruso,M., Silletta,M., Dei Tos,A. P., Gronchi,A., Stacchiotti,S., Santini,D. (...)ESMO Open
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genesFachal,L., Aschard,H., Beesley,J., Barnes,D. R., Allen,J., Kar,S., Pooley,K. A., Dennis,J., Michailidou,K., Turman,C., Soucy,P., Lemaçon,A., Lush,M., Tyrer,J. P., Ghoussaini,M., Marjaneh,M. M., Jiang,X., Agata Simona, Aittomäki,K., Alonso,M. R. (...)Nature genetics
Health outcomes and direct healthcare costs in patients with Melanoma: Associations with level of educationBuja,A., Rivera,M., Zorzi,M., Sperotto,M., Baracco,S., Italiano,I., Vecchiato Antonella, Del Fiore Santo Paolo, Avossa,F., Corti,M. C., Guzzinati,S., Saia,M., Baldo,V., Rugge,M., Rossi Carlo RiccardoActa Dermato-Venereologica
Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITACodolo,G., Toffoletto,M., Chemello,F., Coletta,S., Soler Teixidor,G., Battaggia,G., Munari Giada, Fassan,M., Cagnin,S., de Bernard,M.Frontiers in immunology
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysisSchettini,F., Pascual,T., Conte,B., Chic,N., Brasó-Maristany,F., Galvàn,P., Marìnez,O., Adamo,B., Vidal,M., Muñoz,M., Fernàndez-Martinez,A., Rognoni,C., Griguolo Gaia, Guarneri Valentina, Conte PierFranco, Locci,M., Brase,J. C., Gonzalez-Farre,B., Villagrasa,P., De Placido,S. (...)Cancer treatment reviews
Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)Casanova,M., Brennan,B., Alaggio,R., Kelsey,A., Orbach,D., van Noesel,M. M., Corradini,N., Minard-Colin,V., Zanetti,I., Bisogno,G., Gallego,S., Merks,J. H. M., De Salvo Gian Luca, Ferrari,A.European Journal of Cancer
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trialBarni,S., Rosati,G., Lonardi Sara, Pella,N., Banzi,M., Zampino,M. G., Dotti,K. F., Rimassa,L., Marchetti,P., Maiello,E., Artioli,F., Ferrari,D., Labianca,R., Bidoli,P., Zaniboni,A., Sobrero,A., Iaffaioli,V., De Placido,S., Frassineti,G. L., Ciarlo,A. (...)Therapeutic advances in medical oncology
Laparoscopic hyperthermic intraperitoneal chemotherapy for appendiceal tumorsSommariva Antonio, Tonello Marco, De Simoni,O., Barina,A., Rossi Carlo Riccardo, Pilati PierluigiAsian journal of endoscopic surgery
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study)Antonelli,A., Palumbo,C., Noale,M., Artibani,W., Bassi,P., Bertoni,F., Bracarda,S., Bruni,A., Corvò,R., Gacci,M., Magrini,S. M., Montironi,R., Porreca,A., Tubaro,A., Zagonel Vittorina, Maggi,S., and the Pros-IT CNR study groupMinerva urologica e nefrologica
Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockadeBrasó-Maristany,F., Griguolo Gaia, Pascual,T., Parè,L., Nuciforo,P., Llombart-Cussac,A., Bermejo,B., Oliveira,M., Morales,S., Martìnez,N., Vidal,M., Adamo,B., Martìnez,O., Pernas,S., López ,R., Muñoz ,M., Chic,N., Galván ,P., Garau,I., Manso,L. (...)Nature Communications
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesLoupakis Fotios, Depretis Ilaria, Biason Paola, Intini,R., Prete Alessandra Anna, Leone,F., Lombardi,P., Filippi,R., Spallanzani,A., Cascinu,S., Bonetti,L. R., Maddalena,G., Valeri,N., Sottoriva,A., Zapata,L., Salmaso,R., Munari Giada, Rugge,M., Dei Tos,A. P., Golovato,J. (...)Oncologist
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup AnalysisRosati,G., Galli,F., Cantore,M., Bergamo Francesca, Banzi,M., Zampino,M. G., Mattioli,R., Cardellino,G. G., Ronzoni,M., Di Bartolomeo,M., Tamberi,S., Marchetti,P., Rimassa,L., Corsi,D., Bochicchio,A. M., Artioli,F., Labianca,R., Galli,F., Rulli,E., Bilancia,D. (...)Oncologist
Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumabCaccese Mario, Barbot,M., Ceccato,F., Padovan,M., Gardiman,M. P., Fassan,M., Denaro,L., Emanuelli,E., D'Avella,D., Scaroni,C., Zagonel Vittorina, Lombardi GiuseppeAnti-Cancer Drugs
Re: A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CTEvangelista Laura, Sepulcri MatteoClinical nuclear medicine
Real-world data for direct stage-specific costs of melanoma healthcareBuja,A., Rivera,M., De Polo,A., Zorzi,M., Carpin,E., Vecchiato Antonella, Del Fiore Santo Paolo, Martin,G., Saia,M., Baldo,V., Rugge,M., Rossi Carlo RiccardoThe British journal of dermatology
Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditionsSernicola,A., Russo,I., Silic-Benussi Micol, Ciminale Vincenzo, Alaibac,M.Expert Opinion on Biological Therapy
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinomaBoscolo-Rizzo,P., Giunco,S., Rampazzo,E., Brutti Martina, Spinato,G., Menegaldo,A., Stellin,M., Mantovani,M., Bandolin,L., Rossi,M., Del Mistro Annarosa, Tirelli,G., Dei Tos,A. P., Guerriero,A., Niero,M., Da Mosto,M. C., Polesel,J., De Rossi AnitaJournal of cancer research and clinical oncology
Reflectance Confocal Microscopy in Evaluating Skin Cancer: A Clinicians's PerspectiveFiloni Angela, Alaibac,M.Frontiers in Oncology